三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
ASC41与Resmetirom临床数据对比
ASC41与Resmetirom临床数据对比
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:66KB
图片尺寸:1206*881
同报告图片
/
4
fCBBU0M0MSAxMncgNG1nIFFEIHwgUmVzbWV0aXJvbSAxNncgMTAwbWcgUUQgfCBSZXNtZXRpcm9tIDI0dyAxMDBtZyBRRCB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgLTU1JSAgICAgICAgICAgICAgfCAtMzclICAgICAgICAgICAgICAgICAgICAgIHwgLTE2JSAgICAgICAgICAgICAgICAgICAgICB8CnwgLTI4JSAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrmrYznpLzliLboja/lhazlj7jmnZDmlpnvvIzljY7ms7DnoJTnqbY=
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
所属报告:
海思科 -公司研究报告-十余载耕耘开花结果开启创新时代-240513(50页).pdf
打包全文图表
相关数据
HTD1801与Lanifibranor、Resmetirom(Rezdiffra)的II期临床试验结果对比
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
收藏
行业数据
2025-05-29
原图定位
查看详情
Resmetirom具有良好的安全性
fCDnl4fnirYgfCBQbGFjZWJvIHwgUmVzbWV0aXJvbSwgODAgbWcgfCBSZXNtZXRpcm9tLCAxMDAgbWcgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg6IW55rO7IHwgMTUuNiB8IDI3LjAgfCAzMy40IHwKfCDmgbblv4MgfCAxMi41IHwgMjIuMCB8IDE4LjkgfAp8IOS4pemHjeS4jeiJr+S6i+S7tiB8IDExLjUgfCAxMC45IHwgMTIuNyB8CgrotYTmlpnmnaXmupDvvJrjgIpOLiBFbmdsLiBKIE1lZC7jgIs=
收藏
行业数据
2025-03-14
原图定位
查看详情
VK2809与Resmetirom的MRI-PDFF对比
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
收藏
其它
2024-05-15
原图定位
查看详情
Resmetirom针对NASH的关键性III临床试验数据
fCDpobnnm64gfCBQbGFjZWJvIHwgUmVzbWV0aXJvbSA4MCBtZyB8IFJlc21ldGlyb20gMTAwIG1nIHwKfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfAp8IE5BU0ggUmVzb2x1dGlvbiB8IDEwJSB8IDI2JSB8IDMwJSB8Cnwg4omlMSBTdGFnZSBGaWJyb3NpcyBJbXByb3ZlbWVudCB8IDE0JSB8IDI0JSB8IDI2JSB8CnwgTERMIENob2xlc3Rlcm9sIHwgMCUgfCAtMTQlIHwgLTE2JSB8CgrotYTmlpnmnaXmupDvvJpNYWRyaWdhbCBQaGFybWFjZXV0aWNhbHMg5a6Y572R77yM6LSi5L+h6K+B5Yi4
收藏
其它
2024-01-10
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
HSK31679:国内 THR-β第一梯队选手,具备后发赶超潜力 THR-β持续迭代,后起之秀各有优势。Resmetirom 做为首个 FDA 获批 MASH 新药充分验证了 THR-β成药性,后续一众布局领先的企业有望跟进 me better 研发,快速抢占市场。从当前披露临床数据看,Viking 的 VK2809、歌礼的 ASC41 等后起之秀疗效上各有亮点(非头对头,对比仅供参考)。
其它
原图定位
当前图表所属:
海思科 -公司研究报告-十余载耕耘开花结果开启创新时代-240513(50页).pdf
2012-2023年中国样本医院丙泊酚销量变化
海思科PB-Bands
海思科PE-Bands
2018-1Q2024公司现金流
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》